Table 3.
Clinicopathological details for patients where the BTA recommended a personalised decision-making approach (n = 178)
| PDM recommended for surgical management (n = 32) | PDM recommended for RRA management (n = 80) | |
|---|---|---|
| Had thyroidectomy/RRA | 31 (97%) | 66 (83%) |
| Female | 25 (78%) | 66 (83%) |
| Age, years | 37±10 | 43±15 |
| Papillary cancer | 28 (88%) | 70 (88%) |
| Follicular cancer | 4 (13%) | 10 (12%) |
| Size, mm | 21 (2–40) | 22 (10–40) |
| <1 cm | 8 (25%) | 1 (1%) |
| 1–4 cm | 24 (75%) | 79 (99%) |
| >4 cm | 0 (0%) | 0 (0%) |
| Multifocal disease | 4 (all microPTC) | 30 (38%) |
Values are presented as n (%), mean ± SD, or median (range). BTA, British Thyroid Association; microPTC, papillary thyroid microcarcinoma; PDM, personalised decision-making; RRA, radioiodine remnant ablation.